Shin, S.; Lim, S.; Song, J.Y.; Kim, D.; Choi, M.J.; Gadhe, C.G.; Park, A.Y.; Pae, A.N.; Kim, Y.K.
Development of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent. Pharmaceutics 2019, 11, 497.
https://doi.org/10.3390/pharmaceutics11100497
AMA Style
Shin S, Lim S, Song JY, Kim D, Choi MJ, Gadhe CG, Park AY, Pae AN, Kim YK.
Development of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent. Pharmaceutics. 2019; 11(10):497.
https://doi.org/10.3390/pharmaceutics11100497
Chicago/Turabian Style
Shin, Seulgi, Sungsu Lim, Ji Yeon Song, Dohee Kim, Min Jeong Choi, Changdev G. Gadhe, A Young Park, Ae Nim Pae, and Yun Kyung Kim.
2019. "Development of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent" Pharmaceutics 11, no. 10: 497.
https://doi.org/10.3390/pharmaceutics11100497
APA Style
Shin, S., Lim, S., Song, J. Y., Kim, D., Choi, M. J., Gadhe, C. G., Park, A. Y., Pae, A. N., & Kim, Y. K.
(2019). Development of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent. Pharmaceutics, 11(10), 497.
https://doi.org/10.3390/pharmaceutics11100497